The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predicting early relapse in patients with BRAFV600E melanoma with a highly sensitive blood BRAF assay.
Ryan J. Sullivan
No relevant relationships to disclose
Donald P. Lawrence
No relevant relationships to disclose
Keith T. Flaherty
No relevant relationships to disclose
David F. McDermott
No relevant relationships to disclose
Julie Aldridge
No relevant relationships to disclose
Daniel C. Cho
No relevant relationships to disclose
Rachel Simonson
No relevant relationships to disclose
Virginia Jean Seery
No relevant relationships to disclose
F. Stephen Hodi
No relevant relationships to disclose
Michael B. Atkins
No relevant relationships to disclose
James Walter Mier
No relevant relationships to disclose
David J Panka
No relevant relationships to disclose